We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.59B
AUM Growth
+$283M
Cap. Flow
+$228M
Cap. Flow %
14.35%
Top 10 Hldgs %
6.1%
Holding
1,532
New
540
Increased
294
Reduced
266
Closed
432

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$11.9M
2
BMO icon
Bank of Montreal
BMO
+$10.5M
3
HPQ icon
HP
HPQ
+$9.75M
4
AER icon
AerCap
AER
+$9.53M
5
ITW icon
Illinois Tool Works
ITW
+$8.27M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$8.73M
2
SYF icon
Synchrony
SYF
+$8.42M
3
CAH icon
Cardinal Health
CAH
+$7.63M
4
BRO icon
Brown & Brown
BRO
+$7.55M
5
UL icon
Unilever
UL
+$7.37M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Financials 17.36%
3 Industrials 17.08%
4 Consumer Discretionary 12.43%
5 Healthcare 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMC icon
1176
Commercial Metals
CMC
$8B
-29,805
Closed -$1.37M
CNXC icon
1177
Concentrix
CNXC
$1.5B
-8,926
Closed -$497K
COHU icon
1178
Cohu
COHU
$2.66B
-53,583
Closed -$788K
COP icon
1179
ConocoPhillips
COP
$153B
-18,861
Closed -$1.98M
CPK icon
1180
Chesapeake Utilities
CPK
$3.25B
-5,920
Closed -$760K
CRC icon
1181
California Resources
CRC
$4.75B
-23,608
Closed -$1.04M
CRNX icon
1182
Crinetics Pharmaceuticals
CRNX
$8.96B
-7,048
Closed -$236K
CSL icon
1183
Carlisle Companies
CSL
$15.2B
-1,081
Closed -$368K
CSTL icon
1184
Castle Biosciences
CSTL
$960M
-45,849
Closed -$918K
CSW
1185
CSW Industrials
CSW
$5.65B
-8,782
Closed -$2.56M
CTAS icon
1186
Cintas
CTAS
$81.4B
-13,278
Closed -$2.73M
CSX icon
1187
CSX Corp
CSX
$92.8B
-9,841
Closed -$290K
CTBI icon
1188
Community Trust Bancorp
CTBI
$1.42B
-20,252
Closed -$1.02M
CVGW
1189
DELISTED
Calavo Growers
CVGW
-21,411
Closed -$514K
CVS icon
1190
CVS Health
CVS
$121B
-24,270
Closed -$1.64M
CW icon
1191
Curtiss-Wright
CW
$26.7B
-2,008
Closed -$637K
CX icon
1192
Cemex
CX
$16.2B
-42,864
Closed -$240K
D icon
1193
Dominion Energy
D
$59.8B
-79,512
Closed -$4.46M
DAL icon
1194
Delta Air Lines
DAL
$59.1B
-92,168
Closed -$4.02M
DASH icon
1195
DoorDash
DASH
$92.1B
-6,558
Closed -$1.2M
DCO icon
1196
Ducommun
DCO
$3.04B
-12,405
Closed -$720K
DCOM icon
1197
Dime Commercial Bancshares
DCOM
$1.81B
-19,241
Closed -$536K
DFH icon
1198
Dream Finders Homes
DFH
$1.31B
-35,408
Closed -$799K
DGX icon
1199
Quest Diagnostics
DGX
$26.2B
-5,110
Closed -$865K
DIOD icon
1200
Diodes
DIOD
$4.93B
-42,236
Closed -$1.82M

Similar funds

Campbell & Co Investment Adviser's Q2 2025 Portfolio in Review

As of Q2 2025, Campbell & Co Investment Adviser held 1,532 positions worth $1.59B, up 22% from $1.3B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Campbell & Co Investment Adviser deployed $228M of net new capital in Q2 2025, opening 540 new positions and adding to 294 existing holdings. Its largest new stake was Johnson Controls International: 128,951 shares worth $13.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 9.9% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cardinal Health, an estimated $7.63M trimmed.

  • Campbell & Co Investment Adviser's largest Q2 2025 buy was Johnson Controls International: 128,951 shares worth $13.6M.
  • Campbell & Co Investment Adviser added most to Dover in Q2 2025, an estimated $7.63M increase.
  • Campbell & Co Investment Adviser's biggest Q2 2025 reduction was Cardinal Health, cutting an estimated $7.63M.
  • Campbell & Co Investment Adviser fully exited Labcorp in Q2 2025, selling an estimated $8.73M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6.1% of its $1.59B portfolio in Q2 2025.
  • Campbell & Co Investment Adviser opened 540 new positions and closed 432 in Q2 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 22% quarter-over-quarter to $1.59B.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.